John R. van Nagell, Jr is an American Cancer Society Professor of Clinical Oncology.
Original Article
You have full text access to this OnlineOpen article
Ovarian cancer screening with annual transvaginal sonography
Findings of 25,000 women screened
Article first published online: 20 MAR 2007
DOI: 10.1002/cncr.22594
Copyright © 2007 American Cancer Society
Additional Information
How to Cite
van Nagell, J. R., DePriest, P. D., Ueland, F. R., DeSimone, C. P., Cooper, A. L., McDonald, J. M., Pavlik, E. J. and Kryscio, R. J. (2007), Ovarian cancer screening with annual transvaginal sonography. Cancer, 109: 1887–1896. doi: 10.1002/cncr.22594
Publication History
- Issue published online: 18 APR 2007
- Article first published online: 20 MAR 2007
- Manuscript Accepted: 16 JAN 2007
- Manuscript Revised: 5 JAN 2007
- Manuscript Received: 24 OCT 2006
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , Current developments in ovarian cancer screening, Expert Review of Obstetrics & Gynecology, 2012, 7, 2, 131
- 2
- 3, , Ovarian incidentaloma, Best Practice & Research Clinical Endocrinology & Metabolism, 2012, 26, 1, 105
- 4, , Screening for ovarian cancer in the general population, Best Practice & Research Clinical Obstetrics & Gynaecology, 2012, 26, 2, 243
- 5
- 6, , , âPrimary peritonealâ high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer, Gynecologic Oncology, 2011, 120, 3, 470
- 7, , , , , , , , , , Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: A promising step towards screening and early detection, Gynecologic Oncology, 2011, 120, 3, 385
- 8, , , , , Az ultrahangvizsgálat szerepe a méhtest és a petefészek rosszindulatú daganatainak diagnosztikájában, Orvosi Hetilap, 2011, 152, 47, 1887
- 9, , Dépistage du cancer de lâovaire : le point en 2011, Imagerie de la Femme, 2011, 21, 2, 45
- 10, , Early Detection of Breast, Cervical, Ovarian and Endometrial Cancers in Low Resource Countries: An Integrated Approach, Indian Journal of Surgical Oncology, 2011, 2, 3, 165
- 11, , , Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass, Journal of Gynecologic Oncology, 2011, 22, 4, 244
- 12, , , , , , , , , Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care, Lab on a Chip, 2011, 11, 20, 3411
- 13, , , , , , , , , , Long-Term Survival of Women With Epithelial Ovarian Cancer Detected by Ultrasonographic Screening, Obstetrics & Gynecology, 2011, 118, 6, 1212
- 14
- 15, Measuring success in ovarian cancer risk reducing strategies, Cancer, 2011, 117, 12Direct Link:
- 16, , , Modern Trends into the Epidemiology and Screening of Ovarian Cancer. Genetic Substrate of the Sporadic Form, Pathology & Oncology Research, 2011, 18, 2, 135
- 17, , , , , , , , , , , , , , Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial, Gynecologic Oncology, 2011, 120, 3, 474
- 18, , , , , , Potential Markers for Detection and Monitoring of Ovarian Cancer, Journal of Oncology, 2011, 2011, 1
- You have free access to this content19, , , , , , , , , , , , , Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force, European Journal of Neurology, 2011, 18, 1Direct Link:
- 20, , , , , , , , , , The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses, Clinical Chemistry and Laboratory Medicine, 2011, 49, 12, 2081
- 21, , Ultrasound and Ovarian Cancer Screening: Is There a Future?, Journal of Minimally Invasive Gynecology, 2011, 18, 1, 24
- 22, , , , , Ultrasound for evaluation of adnexal malignancy: From 2D to 3D ultrasound, Journal of Obstetrics and Gynaecology Research, 2011, 37, 10Direct Link:
- 23
- 24
- 25, , , , , , , , , , , , , ACR Appropriateness Criteria© Ovarian Cancer Screening, Ultrasound Quarterly, 2010, 26, 4, 219
- 26, , , Imaging of Benign Adnexal Masses, Topics in Magnetic Resonance Imaging, 2010, 21, 4, 213
- 27
- 28, , , , , , , Ovarian cancer biomarkers for molecular biosensors and translational medicine, Expert Review of Molecular Diagnostics, 2010, 10, 8, 1069
- 29
- 30, , , , , , , , , , , Predicting Risk of Malignancy in Adnexal Masses, Obstetrics & Gynecology, 2010, 115, 4, 687
- 31, , , , , , , , , Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial, American Journal of Obstetrics and Gynecology, 2010, 202, 4, 373.e1
- 32, , , , , , , , , , , Risk of malignancy in sonographically confirmed septated cystic ovarian tumors, Gynecologic Oncology, 2010, 118, 3, 278
- 33, , , , , , , Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass, Gynecologic Oncology, 2010, 117, 3, 440
- 34, , , , , , , SGO White Paper on Ovarian Cancer: Etiology, Screening and Surveillance, Gynecologic Oncology, 2010, 119, 1, 7
- 35, , , , , , Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: A case analysis, Gynecologic Oncology, 2010, 119, 2, 278
- 36, , , , , , , The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review, British Journal of Cancer, 2010, 103, 11, 1657
- 37, , , Imaging of Benign Adnexal Masses: Characteristic Presentations on Ultrasound, Computed Tomography, and Magnetic Resonance Imaging, Clinical Obstetrics and Gynecology, 2009, 52, 1, 21
- 38
- 39, , Ovarian Cancer: Detection and Radiologic Staging, Clinical Obstetrics and Gynecology, 2009, 52, 1, 73
- 40, , , , , , , , , Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors, Clinical Chemistry and Laboratory Medicine, 2009, 47, 5, 537
- 41
- 42, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), The Lancet Oncology, 2009, 10, 4, 327
- 43, , , , , , , , , , The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer, Cancer, 2009, 115, 16Direct Link:
- 44, The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer, Cancer, 2009, 115, 16Direct Link:
- 45, , , , , , , Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome, Cancer, 2008, 113, 2Direct Link:
- 46
- 47
- 48, , , , Place et intérêt de la tomographie par cohérence optique en gynécologie, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2007, 36, 8, 749
- 49, , , Strategies for Ovarian Cancer Prevention, Obstetrics and Gynecology Clinics of North America, 2007, 34, 4, 667
- 50, , , , , , , , , , , , , Screening for Tumours in Paraneoplastic Syndromes,Direct Link:

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)